CTRI/2015/07/005969已完成4 期
Comparative evaluation between 2 g single dose azithromycin and standard azithromycin dosing in uncomplicated skin and soft tissue infections
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 入组人数
- 294
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •ï?§Subjects of either sex aged at least 12 years.
- •ï?§Clinically defined cases of uncomplicated skin and skin structure infection like folliculitis, impetigo, ecthyma, erysipelas, minor abscesses or cellulitis.
- •ï?§Able to complete informed consent process or, if minor, availability of a legally acceptable representative who would be able to complete this process. Subjects between 12-18 years of age would need to assent to the process.
- •ï?§Willing to complete the study protocol, study related activities, and visits.
- •ï?§Able to take oral antibiotic therapy, either in pill or suspension form.
排除标准
- •ï?§Hospital in-patients or history of hospitalization within last 14 days.
- •ï?§Pregnancy or breast-feeding.
- •ï?§Complicated skin and soft tissue infection, such as catheter or catheter site infection within 30 days of placement, surgical site infection, known or suspected prosthetic site infection, unusual exposure history (e.g. underwater injury, fish-tank exposure, heavy soil exposure etc.
- •ï?§infection at the site of an area of underlying skin disease such as chronic eczema, psoriasis, atopic dermatitis, or chronic venous stasis
- •ï?§Diagnosed or suspected disseminated or severe staphylococcal or Group A streptococcal infection including lymphangitic spread of skin infection, septicemia, bacteremia, pneumonia, endocarditis, osteomyelitis, septic arthritis, gangrene, necrotizing fasciitis, myositis, or other serious infection.
- •ï?§Infection at an anatomical site requiring specialized management or specialized antimicrobial therapy including periauricular or orbital infection, perirectal infection, suspected deep space infection of the hand or foot, bursitis or mastitis.
- •ï?§Significant systemic signs such as fever > 101 ï?°F.
- •ï?§Systemic antibacterial therapy within last 14 days.
- •ï?§The following concomitant medications: warfarin, phenytoin, methotrexate, or sulfonylureas and systemically administered antibacterial agents with antistaphylococcal activity.
- •ï?§Any serious disorder of vital organs like liver, kidney, heart, lungs or bone marrow.
- •ï?§History of underlying immunocompromising condition or immunodeficiency.
- •ï?§History of allergy to azithromycin.
- •ï?§History of alcohol or substance abuse.
- •ï?§Participation in another clinical trial within last 30 days.
- •ï?§Any other condition, which, in the opinion of the investigator, would render the subject unsuitable for participation in the trial.
研究者
相似试验
已完成
不适用
arrow Band Ultraviolet (NBUVB) effect on the treatment of inflammatory acneAcne vulgaris.Acne vulgarisIRCT201112288550N1Ahvaz Jundishapur University of Medical Sciences94
招募中
3 期
Comparison of the Efficacy of the Azithromycin and in Combination with Moxifloxacin on Chlamydial CervicitisIRCT20100130003226N16Shahid Beheshti University of Medical Sciences120
尚未招募
2 期
Azithromycin and ceftriaxone verses ceftriaxone alone in a case of prelabour cesarean birth to decrease surgical site infectioCTRI/2024/04/065067Dr. Yogesh baburao Munde
尚未招募
4 期
The effectiveness of azithromycin alone and azithromycin plus cefixime for the treatment of typhoid fever in South Asia has been studied.CTRI/2021/10/037047The University of Oxford
已完成
不适用
Ondansetron effect on headache after spinal anesthesiaPost spinal Punctur Headache.Other complications of spinal and epidural anaesthesia during the puerperiumIRCT2016090629732N1Arak University of Medical Sciences180